Robert MacLeod
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Robert A. MacLeod started working at ADARx Pharmaceuticals, Inc. in 2023.
The current position held is Chief Scientific Officer at ADARx Pharmaceuticals, Inc. since 2023.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-25 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-01-01 |
| Företag | Position | Slut |
|---|---|---|
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Teknisk/Vetenskaplig/F&U Direktör | 2022-12-01 |
| IONIS PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-09-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån